STipe Therapeutics
Platform dedicated to harnessing the innate immune system to battle cancer.
1
Funding Rounds
$22.0m
Money raised
Overview
Platform dedicated to harnessing the innate immune system to battle cancer.
- Website:
- Business model: B2B
- Headquarters: Aarhus
Funding series
Funding Series Analysis
The company STipe Therapeutics has raised a total of $22m in funding over 1 rounds.
Key Insights:
- STipe Therapeutics September 2019 Series A Funding Round: $22m
STipe Therapeutics September 2019 Series A Funding Round
$22m
Industries
STipe Therapeutics is active in the following industries: